States settle with former Heritage execs in generic drug price-fixing case
MLex Summary: Forty-one states and territories have reached settlement agreements with Jason Malek, the former president of Heritage Pharmaceuticals, and Jeffrey Glazer, the former chairman and chief executive officer of Heritage...To view the full article, register now.
Already a subscriber? Click here to view full article